Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Francesco Rubino(King's College Hospital), Bruce M. Wolfe(Oregon Health & Science University), Deepak L. Bhatt(Mount Sinai Hospital), Carel W. le Roux(University College Dublin), Stephanie A. Amiel(King's College London), Jianping Weng(University of Science and Technology of China), Richard W. Grant(Kaiser Permanente), Linong Ji(Peking University), Gerry Rayman(East Suffolk and North Essex NHS Foundation Trust), Gema Frühbeck(Instituto de Salud Carlos III), Josép Vidal(Instituto de Salud Carlos III), Stefano Del Prato(University of Pisa), Paul Zimmet(Monash University), Nizar Albache, Seán F. Dinneen, John M. Morton(Yale University), Tracy Kelly(University of Virginia), Anita P. Courcoulas(University of Pittsburgh Medical Center), Tomasz Klupa, Camilo Boza(Adolfo Ibáñez University), Judith Körner(Columbia University), Sayeed Ikramuddin(University of Minnesota Medical Center), Geltrude Mingrone(University of the Sacred Heart), William H. Herman(University of Michigan), Sangeeta R. Kashyap(Cornell University), Ricardo V. Cohen(Hospital Alemão Oswaldo Cruz), Paola Fioretto(University of Padua), John B. Dixon(Swinburne University of Technology), Philip R. Schauer(Pennington Biomedical Research Center), Lee M. Kaplan(Dartmouth College), Gaspar Taroncher‐Oldenburg(Philadelphia University), William T. Cefalu(National Institutes of Health), Robert E. Ratner(W.K. Kellogg Foundation), Jeffrey I. Mechanick(Mount Sinai Hospital), Rachel L. Batterham(University College Hospital), Robert H. Eckel(University of Colorado Anschutz Medical Campus), Blandine Laferrère(Columbia University Irving Medical Center), Desmond G. Johnston(Imperial College Healthcare NHS Trust), Ele Ferrannini(Powertech Technology (Taiwan)), Wei‐Jei Lee(China Medical University), S.M. Sadikot(India Diabetes Research Foundation), Luc Van Gaal(Inserm), David E. Cummings(VA Puget Sound Health Care System), K. G. M. M. Alberti(Imperial College London), Harvey J. Sugerman, Harold E. Lebovitz(State University of New York), Michel Gagner(Hôpital du Sacré-Cœur de Montréal), David M. Nathan(Harvard University), Walter J. Pories(East Carolina University)
Cited by 969
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
|Journal of the American College of Cardiology|2013|4k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k